Xue Luo

Experienced medical professional with a clinical background in ophthalmology and neuro-ophthalmology research, now leading global clinical strategy and end-to-end R&D operations in pharmaceutical development. Key performance highlights: Solely responsible for the full spectrum of phase III Atogepant clinical trials in China, covering global strategy, trial design, execution, and regulatory submission; active leadership in cross-disciplinary research (neurology, psychiatry, ophthalmology, obesity); expert in managing the entire clinical research lifecycle and driving innovative therapies to market.